[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
RE: Radiation hypersensitivity
There is a genetic disorder that causes patients to be hypersensitive to
ionizing radiation - Atxia telangectasia. Cells from these patients are
about three times more sensitive than cells from normal individuals.
Clinical treatment with therapeutic doses of radiation causes such serious
problems (e.g, necrosis, etc.) that they are never irrdiated.
These patients are usually diagnosed early in life becuase they exhibit
serious symptons such as loss of motor control and very prominent blood
vessels in the skin. By the time they are teenagers they are confined to a
wheelchair and most die as young adults.
Ataxia telangectasia strikes about 1 in 100,000 children. This disease is
caused by homozygous recessive mutations in the two AT alleles. It has been
hypothesized that heterozygous mutations (one allele mutant and the other
normal) might render the patient sensitive to ionizing radiation. Although
the disease is rare, it has been hypothesized that up to 10 percent of
woment diagnosed with breast cancer carry the heterozyous mutation. It is
important to note that this connection is still theoretical - there is no
solid evidence as yet.
However, these patients exhibit no outward symptoms. The gene was cloned
some five years ago and several groups are developing tests for these
mutations.
Patients who enter a radiation oncology clinic for therapeutic treatment
show a broad range of responses. Approximately 5% rapidly develop such
serious side effects that treatment must be suspended or halted altogether.
However, these symptons develop after doses of about 20 Gy. To date, there
is no test that is specifically designed to detect these individuals.
Confessions of a reformed radiation biologist.
Thomas L. Morgan, Ph.D.
Director of Health Physics
Radiation Safety Officer
661-309-1033
-----Original Message-----
From: Jerry Cohen [mailto:jjcohen@PRODIGY.NET]
Sent: Wednesday, October 10, 2001 2:23 PM
To: radsafe@list.vanderbilt.edu; rad-sci-l@ans.ep.wisc.edu
Subject: Radiation hypersensitivity
From: Prof.Dr.Klaus.Becker <Prof.Dr.Klaus.Becker@t-online.de>
>We should perhaps think a little about this question of "radiation
>allergy"
> and how to deal with it, before it is (technically and legally) feasible
to
> do large-scale genetic screening, e.g. of radiation workers. Obviously,
>the
> percentage must be small, but does any of you have good data or arguments?
I think the possibility that some individuals may be hypersensitive to
radiation deserves serious consideration. A good analogy to this situation
can be found in the field of Industrial Hygiene as pertains to Beryllium
exposure. From past observations it is apparent that the most workers who
have experienced high levels of exposure exhibit no harmful effects, while
a certain few show very serious effects and death from even the slightest
exposure.
Given a situation of this nature, how should we determine what a "safe"
exposure level should be?
>From a societal standpoint, is it in the best interests of public health to
protect the most sensitive person, or what? Considering that some people may
be sensitive (allergic) to just about anything, to what extent should we go
to: (a) find such people and isolate them from possible exposure, or (b)
restrict or eliminate the offending agent from use? One problem I envision
assuming that some day we could identify radio-hypersensitive individuals,
should we restrict their travel to high background radiation areas?
[jjcohen@prodigy.net]
************************************************************************
You are currently subscribed to the Radsafe mailing list. To unsubscribe,
send an e-mail to Majordomo@list.vanderbilt.edu Put the text "unsubscribe
radsafe" (no quote marks) in the body of the e-mail, with no subject line.
************************************************************************
You are currently subscribed to the Radsafe mailing list. To unsubscribe,
send an e-mail to Majordomo@list.vanderbilt.edu Put the text "unsubscribe
radsafe" (no quote marks) in the body of the e-mail, with no subject line.